Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment

JAMA Intern Med. 2016 Mar;176(3):300-1. doi: 10.1001/jamainternmed.2015.8320.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anxiety / etiology
  • Anxiety / prevention & control
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Comorbidity
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / psychology
  • Glycated Hemoglobin A / metabolism*
  • Humans
  • Hyperglycemia / prevention & control
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Insulin / administration & dosage
  • Insulin / adverse effects*
  • Male
  • Middle Aged
  • Patient Care Team
  • Patient Participation*

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human